India likely to approve two-dose regimen for COVID vaccines, 4 weeks apart – sources
NEW DELHI — India’s drugs regulator is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally-developed one by Bharat Biotech, each four weeks apart, two sources with knowledge of the matter told Reuters on Saturday. Read More